Mark Bachleda
2023
In 2023, Mark Bachleda earned a total compensation of $711.3K as former Chief Commercial Officer at Galera Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Option Awards | $189,499 |
|---|---|
| Salary | $309,992 |
| Other | $211,818 |
| Total | $711,309 |
Bachleda received $310K in salary, accounting for 44% of the total pay in 2023.
Bachleda also received $189.5K in option awards and $211.8K in other compensation.
Rankings
In 2023, Mark Bachleda's compensation ranked 1,603rd out of 3,001 executives tracked by ExecPay. In other words, Bachleda earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,603 out of 3,001 | 47th |
Division Manufacturing | 939 out of 1,645 | 43rd |
Major group Chemicals And Allied Products | 603 out of 913 | 34th |
Industry group Drugs | 587 out of 876 | 33rd |
Industry Pharmaceutical Preparations | 417 out of 634 | 34th |
Source: SEC filing on January 24, 2025.
Bachleda's colleagues
We found three more compensation records of executives who worked with Mark Bachleda at Galera Therapeutics in 2023.